Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2014
/
Article
/
Fig 2
/
Research Article
Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer
Figure 2
Dose-dependent plots for four of the representable drugs, that is, anisomycin, mefloquine, niclosamide, and trichostatin A (TSA).
(a)
(b)
(c)
(d)